Nieuwe 'dure' kankergeneesmiddelen en kosteneffectiviteitsanalyses: hoe is de stand van zaken?

Carin Uyl - de Groot, Adri Steenhoek

Research output: Contribution to journalArticleProfessional

Original languageUndefined/Unknown
Pages (from-to)28-30
Number of pages3
JournalIKR-bulletin (Rotterdam)
Volume31
Publication statusPublished - 2007

Research programs

  • EMC NIHES-05-63-02 Quality

Cite this